NF-κB Inhibitors Analysis, Clinical Trials, Patents and Developments

NF-κB inhibitors currently exhibit a proliferating pipeline with 10+ therapeutic candidates. NF-κB is a family of transcription factors, aiding many regulatory cellular functions such as regulation of apoptosis, inflammatory responses, cellular growth, and others. Cancer, arthritis, and asthma are some Read more ›